How should I evaluate and manage a patient presenting with tremor?

Evaluation and Management of Tremor

Begin by determining whether the tremor is primarily an action tremor (postural, kinetic, or intention) or a resting tremor through focused history and examination, as this single distinction drives the entire differential diagnosis and management pathway. 1, 2

Initial Clinical Assessment

Key Historical Features to Elicit

• Timing and context of tremor onset: Determine if tremor occurs at rest, with sustained posture (arms outstretched), during movement toward a target, or during specific tasks like writing 1, 2
• Medication and substance history: Many drugs (beta-agonists, valproate, lithium, amiodarone, SSRIs) and caffeine/alcohol can induce or enhance tremor 2, 3
• Family history: Essential tremor shows autosomal dominant inheritance in many cases 3
• Associated neurological symptoms: Look for bradykinesia, rigidity, dystonia, ataxia, or neuropathy 1, 2
• Functional impact: Assess disability in writing, eating, drinking, and social situations 4

Focused Neurologic Examination

• Observe tremor at rest with hands in lap and during mental distraction (counting backwards) to identify parkinsonian tremor 1, 2
• Assess postural tremor with arms outstretched (essential tremor, enhanced physiologic tremor, drug-induced tremor) 1, 2
• Evaluate kinetic tremor during finger-to-nose testing (essential tremor worsens with action; cerebellar tremor shows intention component) 1, 2
• Test for dystonia in the affected body part, as dystonic tremor has distinct treatment implications 1, 2
• Examine for parkinsonian signs: bradykinesia, rigidity, postural instability 2, 3

Differential Diagnosis Framework

Action Tremor Predominant (Most Common)

• Essential tremor: Bilateral postural and kinetic tremor, often affecting hands, head, or voice; may have family history and alcohol responsiveness 1, 2, 3
• Enhanced physiologic tremor: Fine, rapid tremor exacerbated by anxiety, caffeine, hyperthyroidism, or medications 1, 2, 3
• Drug-induced tremor: Temporal relationship with medication initiation 2, 3
• Dystonic tremor: Irregular, jerky tremor with dystonic posturing in the affected body part 1, 2
• Cerebellar tremor: Intention tremor with ataxia, dysmetria, and other cerebellar signs 1, 2
• Orthostatic tremor: High-frequency leg tremor (13-18 Hz) occurring only when standing 1, 2

Resting Tremor Predominant

• Parkinson disease: Asymmetric resting tremor (4-6 Hz) with bradykinesia and rigidity 1, 2, 3
• Drug-induced parkinsonism: Antipsychotics, metoclopramide, valproate 2, 3

Ancillary Testing

In most patients evaluated by an experienced clinician, history and examination alone establish the diagnosis without need for additional testing. 5

When to Order Laboratory Tests

• Thyroid function tests: For suspected hyperthyroidism causing enhanced physiologic tremor 5, 3
• Ceruloplasmin and 24-hour urinary copper: For patients under age 40 with atypical features suggesting Wilson disease 3
• Electromyography (EMG): Rarely needed, but can distinguish tremor frequency patterns when diagnosis is uncertain 5
• DaTscan (dopamine transporter SPECT imaging): To differentiate essential tremor from parkinsonian tremor when clinical examination is equivocal 5

Management of Essential Tremor

Indications for Treatment

Initiate therapy only when tremor interferes with functional activities or quality of life; essential tremor does not shorten life expectancy but can cause greater disability than Parkinson disease in writing, eating, drinking, and social functioning. 4

First-Line Pharmacologic Therapy

• Propranolol (40-320 mg/day) or primidone (starting 25-50 mg at bedtime, titrating to 250-750 mg/day): Both achieve tremor reduction in approximately 50-70% of patients, typically halving tremor severity 4
• When propranolol is contraindicated (COPD, asthma, heart block): Use primidone as the immediate alternative 4

Second-Line Pharmacologic Options

Topiramate (starting 25 mg/day, titrating to 200-400 mg/day) or gabapentin (900-3600 mg/day) may be used when first-line therapies fail or are not tolerated, but they are markedly less effective than propranolol or primidone. 4, 6

Common Pitfall

Do not delay surgical referral when second-line oral agents fail, as these medications are substantially less effective than first-line drugs and patients may suffer unnecessary disability. 4

Surgical and Interventional Management

Indications for MR-Guided Focused Ultrasound (MRgFUS) Thalamotomy

Consider MRgFUS when all three criteria are met: 4

• Confirmed diagnosis of essential tremor, and
• Failed, intolerant of, or contraindicated to at least two medications (one must be propranolol or primidone), and
• Appendicular tremor interferes with quality of life

MRgFUS Efficacy and Safety

• Produces 53-56% tremor improvement at 1-2 years, sustained at 4 years (56% hand tremor improvement, 63% disability improvement) 4
• Serious adverse events occur in only 1.6% of patients 4
• Most common side effects are gait disturbance (36%) and paresthesias (38%), which largely resolve by 1 year (remaining in 9% and 14%, respectively) 4

Contraindications to MRgFUS

• Bilateral MRgFUS thalamotomy 4
• Contralateral to previous thalamotomy 4
• Inability to undergo MRI 4
• Skull density ratio < 0.40 4

Deep Brain Stimulation (DBS)

Bilateral DBS targeting the ventral intermediate nucleus (VIM) of the thalamus is the appropriate choice for patients requiring bilateral intervention, as bilateral MRgFUS is contraindicated. 4, 6

Alternative Ablative Procedures

Radiofrequency thalamotomy and radiosurgical thalamotomy are additional ablative options when MRgFUS or DBS are not feasible. 4, 6